CHEST Congress 2021

virtual 17 October 2021 - 20 October 2021

Lefamulin: An alternative to moxifloxacin in pneumonia treatment?

01 Dec 2021 by

The pleuromutilin inhibitor lefamulin shows similarly high efficacy as moxifloxacin (a standard fluoroquinolone therapy for clearing bacterial pneumonia) regardless of whether it was for unilobar or multilobar pneumonia, according to pooled data of the LEAP* 1 and 2 studies.

Lefamulin: An alternative to moxifloxacin in pneumonia treatment?

01 Dec 2021

Dupilumab benefits in kids with asthma hold out to 52 weeks

28 Nov 2021 by

Dupilumab significantly continues to improve lung function — including measures of the large and small airways — out to 52 weeks in children with uncontrolled, moderate-to-severe asthma, according to 52-week data of the LIBERTY ASTHMA VOYAGE trial.

Dupilumab benefits in kids with asthma hold out to 52 weeks

28 Nov 2021

Prophylactic azithromycin helps prevent asthma attacks

13 Nov 2021 by

Prophylactic use of azithromycin was associated with significantly fewer infections and hospitalizations in patients with asthma, according to real-world data presented during the CHEST 2021 Congress.

Prophylactic azithromycin helps prevent asthma attacks

13 Nov 2021